JAK3 and prolymphocytic leukemia: Activated mutations of JAK3 have been found in a variety of hematopoietic malignancies, including acute myeloid leukemia (AML), T-cell acute lymphoblastic leukemia (T-ALL), and T-cell prolymphocytic leukemia (T-PLL) (1–3).